Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Narayan

Showing results (401-410 of 409) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 409 results.
Interface Focus|December 18, 2023
Constructing bilayer and volumetric atrial models at scaleCaroline H Roney, Jose Alonso Solis Lemus, Carlos Lopez Barrera, et al.
Heart Rhythm|October 18, 2023
Opportunities and challenges in heart rhythm research: Rationale and development of an electrophysiology collaboratoryDuy T Nguyen, Kenneth C Bilchick, Sanjiv M Narayan, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 29, 2025
Peri-procedure and Mid-Long Term Effects of Pulsed Field Ablation vs. Thermal Ablation (Cryo- or Radiofrequency) on Autonomic Nervous System Function in Atrial Fibrillation: A Systematic and Quantitative Pooled-Analysis with Potential Implications for Patient Selection (The PULSE-COLD-HEAT-ANS Collaboration)Sebastian Graeger, Sanjiv M Narayan, Christian Meyer, et al.
Research Square|August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer|February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
The Journal of Urology|May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
The Lancet. Oncology|November 30, 2020
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialStephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, et al.
European Urology|December 22, 2021
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical TrialAnirban P Mitra, Vikram M Narayan, Sharada Mokkapati, et al.
Pageof 41

Showing results (401-410 of 409) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 409 results.
Interface Focus|December 18, 2023
Constructing bilayer and volumetric atrial models at scaleCaroline H Roney, Jose Alonso Solis Lemus, Carlos Lopez Barrera, et al.
Heart Rhythm|October 18, 2023
Opportunities and challenges in heart rhythm research: Rationale and development of an electrophysiology collaboratoryDuy T Nguyen, Kenneth C Bilchick, Sanjiv M Narayan, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 29, 2025
Peri-procedure and Mid-Long Term Effects of Pulsed Field Ablation vs. Thermal Ablation (Cryo- or Radiofrequency) on Autonomic Nervous System Function in Atrial Fibrillation: A Systematic and Quantitative Pooled-Analysis with Potential Implications for Patient Selection (The PULSE-COLD-HEAT-ANS Collaboration)Sebastian Graeger, Sanjiv M Narayan, Christian Meyer, et al.
Research Square|August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer|February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
The Journal of Urology|May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
The Lancet. Oncology|November 30, 2020
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialStephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, et al.
European Urology|December 22, 2021
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical TrialAnirban P Mitra, Vikram M Narayan, Sharada Mokkapati, et al.
Pageof 41